Alcon Inc (ALC)
79.58
-1.18
(-1.46%)
USD |
NYSE |
Apr 24, 15:10
Alcon Profit Margin (Quarterly): 18.15% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.15% |
| September 30, 2023 | 8.76% |
| June 30, 2023 | 6.98% |
| March 31, 2023 | 7.40% |
| December 31, 2022 | -4.47% |
| September 30, 2022 | 5.42% |
| June 30, 2022 | 6.68% |
| March 31, 2022 | 7.67% |
| December 31, 2021 | 6.47% |
| September 30, 2021 | 0.10% |
| June 30, 2021 | 7.16% |
| March 31, 2021 | 4.35% |
| Date | Value |
|---|---|
| December 31, 2020 | 4.90% |
| September 30, 2020 | -8.00% |
| June 30, 2020 | -34.76% |
| March 31, 2020 | -3.10% |
| December 31, 2019 | -4.76% |
| September 30, 2019 | -3.53% |
| June 30, 2019 | -20.49% |
| March 31, 2019 | -5.98% |
| December 31, 2018 | -4.08% |
| September 30, 2018 | -11.75% |
| June 30, 2018 | 0.82% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-34.76%
Minimum
Jun 2020
18.15%
Maximum
Dec 2023
0.26%
Average
4.90%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| AC Immune SA | -32.05% |
| CRISPR Therapeutics AG | 44.67% |
| Addex Therapeutics Ltd | -1.86K% |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -1.92K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.92% |
| Gross Profit Margin (Quarterly) | 54.85% |
| Operating Margin (Quarterly) | 8.84% |